Subscribe to Newsletter
Diagnostics Omics, Oncology, Technology and innovation

Insights & perspectives from a state-of-the-art laboratory in genomic testing

sponsored by Exact Sciences

Register here

June 20, 2024 - 4pm CET

We are delighted to invite you to this webinar, sponsored by Exact Sciences*, on the diagnostic and prognostic power of genomic testing.

Pathology labs play a pivotal role in supporting interdisciplinary teams with accurate markers for personalized treatment decisions. Staying at the forefront of diagnostic innovation requires significant investing and decisive commitment of both human and material resources to effectively integrate disruptive technologies into lab workflows.

Our experienced team will demonstrate how your lab can benefit from external genomic testing expertise. By harnessing this specialist knowledge, pathologists can advance tailored patient care, optimize patient pathways, reduce healthcare costs, and lead diagnostic innovation.

This event is ideal for anyone interested in exploring genomic testing alternatives and leverage opportunities derived from centralized laboratory expertise.

Webinar Learning Objectives

  • Explore Molecular testing as an advanced tool to enhance diagnostic and prognostic accuracy, enabling personalized care for early-stage breast cancer.
  • Gain insights into the operational processes and stringent quality standards upheld by centralized laboratories in genomic testing.
  • Discover how expertise in genomic testing will drive future advancements in clinical research and anatomic pathology, particularly in the evolving field of minimal residual disease (MRD) detection.

Register here

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related Application Notes
Tumor Genomic Profiling with SureSelect Cancer Tumor-Specific Assays

| Contributed by Agilent

Comprehensive Genomic Profiling with SureSelect Cancer CGP Assay

| Contributed by Agilent

Automating Hybrid Capture NGS Workflow on AVENIO Edge

| Contributed by Roche

Related Product Profile
Diagnostics Genetics and epigenetics
QIAseq® Pan Cancer Multimodal cuts user interventions by 50%

| Contributed by QIAGEN

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register